[AVTE] YoY Quarter Result on 30-Jun-2022 [#Q2]

Stock
[AVTE] Aerovate Therapeutics, Inc.
Announcement Date
15-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- -8.94%
YoY- -103.76%
Quarter Report
AVTE's Result
AVTE's Financial Summary
View:
Show?
Quarter Result
30/06/23 30/06/22 30/06/21 30/06/20 CAGR
Revenue 0 0 0 0 -
PBT -19,025 -11,991 -5,775 -2,202 105.19%
Tax -1,312 -224 -2 0 -
NP -19,025 -11,767 -5,775 -2,202 105.19%
Tax Rate - - - - -
Total Cost 19,025 11,767 5,775 2,202 105.19%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 CAGR
NP Margin 0.00 0.00 0.00 0.00 -
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 CAGR
EPS -0.76 -0.48 -23.76 -9.06 -56.22%
EPS Diluted -0.76 -0.48 -23.76 -9.06 -56.22%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.